Close Menu

NEW YORK (GenomeWeb) – Fluidigm has announced that it has entered a co-marketing agreement with Genomenon to offer evidence-based genomic panel design services for translational and clinical disease researchers.

According to the partners, researchers will be able to expedite the design of disease-specific next-generation sequencing, genotyping, and real-time PCR panels using Fluidigm's automated microfluidic systems.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.